featured
Bioresorbable Vascular Scaffolds in Coronary Syndromes: 12-Month Outcomes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JACC: Cardiovascular Interventions
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical, Angiographic, Functional, and Imaging Outcomes 12 Months After Implantation of Drug-Eluting Bioresorbable Vascular Scaffolds in Acute Coronary Syndromes
JACC Cardiovasc Interv 2015 May 01;8(6)770-777, T Gori, E Schulz, U Hink, M Kress, N Weiers, M Weissner, A Jabs, P Wenzel, D Capodanno, T MünzelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.